We examined the effects of FRC-8653, a novel dihydropyridine calcium Calcium antagonists possess potent vasodila tive activity, and their therapeutic usefulness in the treatment of essential hypertension and several types of angina pectoris has been well established (1, 2). Various compounds with a 1,4-dihydropyridine structure have been de veloped with the intent of improving the hy potensive activity of nifedipine, the prototype calcium antagonist. FRC-8653 is a new dihy dropyridine calcium antagonist synthesized by Fujirebio Inc. (3) that has a strong and long lasting action (4). In accordance with the clini cal data, in vitro depolarization experiments using rat arterial preparations have demon strated that the calcium antagonistic activity of FRC-8653 is longer lasting than those of nife dipine and nicardipine (M. Hosono et al., un published data). In the present communica tion, we examined whether the long-lasting calcium antagonistic activity of FRC-8653 was also seen in rat mesenteric arterial prepara tions and whether FRC-8653 had a long-last ing inhibitory activity on the calcium influx through cell membranes.
Calcium antagonists possess potent vasodila tive activity, and their therapeutic usefulness in the treatment of essential hypertension and several types of angina pectoris has been well established (1, 2) . Various compounds with a 1,4-dihydropyridine structure have been de veloped with the intent of improving the hy potensive activity of nifedipine, the prototype calcium antagonist. FRC-8653 is a new dihy dropyridine calcium antagonist synthesized by Fujirebio Inc. (3) that has a strong and long lasting action (4) . In accordance with the clini cal data, in vitro depolarization experiments using rat arterial preparations have demon strated that the calcium antagonistic activity of FRC-8653 is longer lasting than those of nife dipine and nicardipine (M. Hosono et al., un published data). In the present communica tion, we examined whether the long-lasting calcium antagonistic activity of FRC-8653 was also seen in rat mesenteric arterial prepara tions and whether FRC-8653 had a long-last ing inhibitory activity on the calcium influx through cell membranes.
Superior mesenteric arteries from male Splague-Dawley rats (250-350g) were cut into helical strips under a binocular micro scope. Preparations were mounted in an organ bath and incubated at 37°C in oxygenated (95% 02, 5% CO,) physiological salt solution (PSS) of the following composition: 135 mM NaCI, 1 mM MgCl-,, 5 mM KCI, 2 mM CaCl,, 15 mM NaHCO3, and 1 mM glucose (5). The contraction elicited by raising the K+ concen tration to 65 mM was isometrically recorded using a force transducer (TB651T, Nihon Kohden, Tokyo, Japan). Tension was initially set at 0.8 g, and the tissues were equilibrated for 1 hr, after which they were re-tensioned at 0.8 g. Mesenteric arterial preparations were initially contracted by 65 mM KCI as a control response. After removing the high potassium solution, the preparations were treated for 1 hr with one of the following calcium antago nists dissolved in PSS: 1 X 10_9 M, FRC 8653, 5 X 109 M, nifedipine, 3 X 10-10 M nicardipine, and the contractility induced by increasing KCI concentration to 65 mM was repeatedly examined for 7 hr at 1-hr intervals. The arterial preparations were washed 3 times after each contraction by KC1.
The inhibitory effect of FRC-8653 on cal cium influx was tested in the rat vascular smooth muscle cells (A-10). These cells have been confirmed to express voltage-dependent calcium channels (6) . A-10 cells were obtained from The American Type Culture Collection and cultured in Dulbecco's Modified Eagle Medium (DMEM, GIBCO, NY, U.S.A.) sup plemented with 10% fetal bovine serum (FBS) and antibiotics. Assays were carried out on confluent monolayers (4-6 days of subculture in 24-well plates (Corning 25820, NY, U.S.A.)). Studies on net 45Ca`+ influx were performed according to the method of Ruegg et al. (7), with a slight modification. Prior to assay, the medium was aspirated and then the subcultured cells were rapidly washed three times with 2 ml of normal balanced salt solu tion (BSS-n) of the following composition: 145 mM NaCI, 5 mM KCI, 1 mM MgCl2, 0.1 mM CaCl2, 10 mM glucose, and 5 mM HEPES. The incubation for 45Ca2+ influx was started by adding 0.5 ml of balanced salt solu tion for depolarization (BSS-d), which had the following composition: 95 mM NaCI, 55 mM KCI, 1 mM MgCl2, 0.1 mM CaCl2, 10 mM glu cose, 5 mM HEPES and 1 ,ug/ml of 45CaC12. After 30 min, the reaction was terminated by rapidly aspirating BSS-d and washing the cells three times with ice-cold BSS-n containing 10 mM LaC13 and no calcium. The washed cells dissolved in 1 ml of 0.2% SDS were transferred into scintillation vials and 7 ml of Triton-toluene scintillation cocktail was added. In the measurements of the duration of inhibi tory effect on 45Ca2+ influx, cells were initially treated with each calcium antagonist at various doses (1 X 10-7 M, 1 X 10-8 M and 1 X 10-9 M) for 1 hr. The cells were rinsed twice with BSS-n to remove each antagonist at time 0, followed by addition of fresh DMEM with FBS to each well, and incubation was further continued at 37°C. The cells were washed twice with BSS-n at 2 hr intervals, and the 45Ca2+ influx was assayed every 2 hr until 8 hr after removal of the drug.
FRC-8653 was synthesized as the racemic compound at the Central Research Laborato ries, Ajinomoto Co., Kanagawa, Japan. Nifedi pine and nicardipine were obtained from Sig ma Chemical Co., MO, U.S.A. 45CaC12 was obtained from New England Nuclear, MA, U.S.A. The recovery of contractility of rat superior mesenteric arteries suppressed by various cal cium antagonists was determined. As shown in Fig. 1 , the arterial preparation treated with nifedipine recovered complete contractility 2 hr after drug removal. Inhibition caused by nicardipine was slowly restored and about 50% suppression remained at 7 hr after re moval of the drug. In the preparation treated with FRC-8653, inhibition persisted through out the experimental period and approximate ly 70% suppression was still observed 7 hr af ter removal of the drug. Several laboratories have studied the long acting effects of dihy dropyridine calcium antagonists (8) (9) (10) As sources of increased intracellular cal cium, two major mechanisms have become evident. One is the influx of extracellular cal cium ions through the cell membrane and the other is the release from the intracellular cal cium store (11) . Many studies support the view that the vasodilative and calcium antago nistic activities of dihydropyridine calcium antagonists result from blocking the calcium influx through L-channels (8, 12) . Although movement of calcium ions through L-channels has not been directly measured in the previous studies, continuous suppression of vascular contraction brought about by long-lasting cal cium antagonists is generally assumed to result from prolonged suppression of L-channels. To clarify the mechanism of the continuous vaso dilative activity of long-lasting calcium antago nists, calcium influx into vascular smooth muscle cells needs to be directly measured. We therefore tested FRC-8653 for its inhibi tory effect on calcium influx using a rat aortic smooth muscle cell line that has L-type cal cium channels (6) . In BSS-n, 45Ca2+ influx was 1353 ± 56 cpm/well, and it increased to 2486 ± 46 cpm/well in high K+ solution (BSS d). In the presence of nifedipine (1 X 10-7 M), the influx was suppressed to 851 ± 35 cpm/well, lower than that in BSS-n. These are the same results as previous reports that sug gest partially depolarized membrane potential and the partially activated state of L-type cal cium channels (6, 7) of vascular smooth mus cle cells in culture. As shown in Fig. 2 , dihy dropyridine calcium antagonists inhibited the depolarization-induced increase in 45Ca2+ in flux into A10 cells. In the kinetic analysis, partial recovery of 45Ca2+ influx was observed at time 0 in nifedipine treated A10 cells at each drug concentration, suggesting that there was a partial dissociation of nifedipine mole cules from their receptors caused by rinsing with BSS-n before the 45Ca2+ load. After 2 hr, influx restored to the control level at each drug concentration. It took 4 to 8 hr for the influx of the nicardipine-treated cells to return to the conrol level. The restoration of 45Ca2+ influx was the slowest in the cells treated with FRC-8653 and about 30% inhibition still per sisted even after 8 hr at the concentration of 1X10-7M.
Inhibition by each calcium antagonist in the depolarized mesenteric arterial preparations lasted longer than that in the 45Ca2+ influx assay. One reason for this may be that the in flux experiment enables the clearance of cal cium antagonists from cell surfaces because of the coexisting serum proteins in the culture medium. Serum albumin is generally known as the major carrier protein of dihydropyridine calcium antagonists in the blood (13) . In fact, when the depolarization experiment was per formed by rinsing the arterial preparations with PSS which that contained bovine serum albumin, FRC-8653 treated preparations recov ered contractility quickly so that only 25% in hibition was ovserved after 4 hr (data not shown). The other possibility that there maybe a metabolic turn over or internalization of dihydropyridine receptors from the cell mem brane. It is known that there is a turnover of membrane receptors within hours on cultured cell surfaces and that the membrane receptors are internalized into the cytoplasm when ligands bind to them. Therefore the possibility cannot be excluded that there is a turnover of dihydropyridine receptors inactivated by FRC 8653 and/or other calcium antagonists, and new active receptors appear on the cell mem brane.
Oike et al. have observed that racemic FRC-8653 produce both excitatory and inhibi tory effects on the depolarization pulse in duced Ba2+ current in the rabbit basilar artery (14) . The (+) enantiomer mainly has excita tory and (-) enantiomer inhibitory actions at the holding potential of -80 mV. When the holding potential is increased to -40 mV, both enantiomers have an inhibitory action. In the present study, racemic FRC-8653 was uti lized and not excitatory but inhibitory action was observed on the depolarization induced 45Ca2+ influx in A10 cells . This result can be explained by two different assumptions. One possibility is that both the (+) and (-) enan tiomers have inhibitory action under the pres ent experimental conditions. The fact that the A10 cells have partially depolarized membrane potential in culture (15) may support this hypothesis because both enantiomers have in hibitory action at the potential of -40 mV in the rabbit basilar artery. The other is that the (-) enantiomer produces an inhibitory action and the (+) enantiomer produces an excita tory action, but it is weaker than the inhibi tory action of the (-) enantiomer, on the Ca 2+ influx in A10 cells. In this case, racemic FRC-8653 is thought to have a net inhibitory action, as the sum of the contrary actions of the (+) and (-) enantiomers.
The in vitro monitoring of tension in the vascular preparation can be used to evaluate mechanical force and its suppression by cal cium antagonists. The long-lasting inhibitory effect of calcium antagonists on vascular con traction is generally assumed to result from long-lasting inhibition of L-channels (8) (9) (10) , but the direct measurement of calcium influx through L-channels has not been attempted in previous studies. In the present study, we ex amined directly the influx of calcium ions through the cell membrane and confirmed that FRC-8653 inhibited calcium influx for a longer time than nifedipine and nicardipine. This re sult indicates that the long lasting hypotensive and vasodilative activity elicited by FRC-8653 may be maintained by continuous inhibition of calcium influx from the extracellular fluid into vascular smooth muscle cells. Whether this in hibition may be mediated through continuous binding of FRC-8653 to dihydropyridine re ceptors on the vascular smooth muscle re mains to be determined.
